Dr. Mike Y. Chen, MD

Dr. Chen practices at City of Hope Comprehensive Cancer Center - Duarte in Duarte, California.

Dr. Chen's NPI, 1932111986, was assigned on August 11, 2006. Dr. Chen graduated from Sidney Kimmel Medical College in 1996. Dr. Chen holds California license A97834.

Dr. Chen's primary practice is City of Hope Comprehensive Cancer Center - Duarte, at 1500 Duarte Rd, Duarte, CA 91010 in Los Angeles County. The practice phone is (800) 826-4673.

Dr. Chen's primary practice is City of Hope Comprehensive Cancer Center - Duarte in Duarte, California. Dr. Chen is also affiliated with Garfield Medical Center. The medical group on file is City of Hope. Dmand AI also links Dr. Chen to 2 more group practices and clinics, 1 other site and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chen practices, 4 sites in all. Vendor and product names are available with a free account.

Neurological surgery is Dr. Chen's primary specialty in the NPI Registry, under taxonomy code 207T00000X. Dr. Chen is board certified in neurological surgery by the American Board of Neurological Surgery. Dmand AI has Dr. Chen's licenses on file in 3 states: California, Virginia and Maryland.

Dmand AI lists back and neck pain treatment without fusion, craniotomy, lower back pain, muscle pain, fibromyalgia, and limb pain, neck pain and spine problems, spinal fusion and thoracic spine disorders among the conditions Dr. Chen treats.

CMS data shows 337 Medicare services from Dr. Chen across 10 procedure codes in 2024, for 234 Medicare patients. Medicare paid $49,500 for them.

CMS counts 234 Medicare patients who saw Dr. Chen in 2024. The largest group is 65 to 74, with 97 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 47% are also on Medicaid. Their average risk score is 2.81, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chen's median patient age at 66, with 59% women.

In 2024, Dr. Chen wrote 40 Medicare Part D claims for 14 patients. 95% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $192 in total drug cost. In 2021, CMS named 28 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Chen for performance year 2024, reported as part of a group. Dr. Chen accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Chen as offering telehealth. CMS counts 54 procedures of spinal fusion by Dr. Chen, more than 57% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 48 papers to Dr. Chen, published from 2009 to 2024. 2013 was the busiest year, with 5. The most frequent topics are Brain Neoplasms, Breast Neoplasms and Cell Line, Tumor. Dr. Chen has published most often in Neurosurgery. Dr. Chen's most frequent co-authors are Rahul Jandial, MD, PhD, Behnam B. Badie, MD and Mike Kuang Sing Chen, MD.

CMS Open Payments shows 144 general payments to Dr. Chen from 19 drug and device companies from 2016 to 2025. Royalties and licenses make up the largest share, 81% of the total. Globus Medical, Inc. paid the most, $135,339. It also lists 4 research payments totaling $914 from 2017 to 2019.

Dr. Chen graduated from Sidney Kimmel Medical College in 1996. Dr. Chen is a member of AANS and CNS.

Dr. Chen is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.